智翔金泰(688443) - 智翔金泰投资者关系活动记录表(2023年度科创板生物制品（二）集体业绩说明会）

Group 1: Investor Relations Activity Overview - The investor relations activity was conducted on May 22, 2024, from 15:00 to 17:00 [1] - The event was an online performance briefing for the 2023 annual report [1] - Participants included the Chairman, Independent Directors, and the General Manager of the company [1] Group 2: Key Discussion Points - The company was asked to elaborate on its Q1 2024 financial performance, which showed a year-on-year comparison [1] - The company indicated that it has not yet met the conditions for cash dividends but is focused on enhancing overall profitability and accelerating new drug development [1] - Future plans include increasing the frequency of dividend distributions, contingent on meeting regulatory requirements [1]